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Abstract. Pigeons responded under a multiple fixed- 
interval 5-min, 30-response fixed-ratio schedule of 
food reinforcement. Acute pargyline doses between 
10.0 and 50.0 mg/kg (i.m.), given immediately prior 
to the session, decreased responding. Daily admin- 
istration of 50 mg/kg pargyline (24 mg/kg, every 12 h) 
initially decreased responding. Tolerance developed 
so that after 4 days of daily pargyline, responding had 
returned to control values. Chronic pargyline resulted 
in an enhanced sensitivity to the effects of d-amphet- 
amine, ephedrine, tyramine, and morphine on sched- 
ule-controlled responding. Both d-amphetamine and 
pentobarbital increased fixed-interval responding at 
relatively low doses, while higher doses decreased 
responding. Daily pargyline resulted in an increased 
sensitivity to both the increases and decreases in 
response rates produced by d-amphetamine. In con- 
trast, sensitivity to pentobarbital was not changed 
after daily pargyline. Ephedrine, tyramine, and mor- 
phine only decreased fixed-interval responding. Chro- 
nic pargyline resulted in an increased sensitivity to the 
response-rate decreasing effects of ephedrine, tyra- 
mine, and morphine. In addition to the increased 
sensitivity of fixed-interval responding to the effects 
of tyramine, the dose-effect curve for fixed-ratio 
responding was also a shifted to the left. Daily pargy- 
line did not result in changes in sensitivity of fixed- 
ratio responding to the effects of the other drugs 
tested. 
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Indirectly-acting sympathomimetics are thought act 
by releasing biogenic amines from nerve terminals 
(Burn and Rand, 1958; Trendelenburg, 1963). In the 
peripheral nervous system tyramine, d-amphetamine, 
and other indirectly-acting sympathomimeties produce 
their effects on heart rate, blood pressure, bronchial 
smooth muscle tone, etc. by releasing catecholamines 
stored within adrenergic nerves and related tissues 
(Potter and Axelrod, 1963; Trendelenburg, 1963; 
Smith, 1966). 
In addition to their effects on the peripheral 
nervous system, amphetamine and other indirectly- 
acting sympathomimetics produce increases in spon- 
taneous locomotor activity in rodents (Smith, 1963; 
Van Rossum and Hurkmans, 1964; Costa et al., 1972) 
and stimulate, suppress, and reinforce operant re- 
sponding (McMillan, 1968 a, b; Pickens and Thomp- 
son, 1968 ; Tilson and Sparber, 1972; Goldberg, 1973). 
It has been proposed that the stimulation of locomotor 
activity is at least in part due to the drug-induced 
release of catecholamines in the brain (Van Rossum 
and Hurkmans, 1964; Carlsson, 1970). In support of 
this hypothesis, it has recently been demonstrated 
that ventricular perfusion of the cat brain with 
d-amphetamine will cause a release of radiolabeled 
dopamine into the lateral ventricle (Chiueh and Moore, 
1975). In addition, drugs that inhibit the conversion 
of tyrosine to catecholamines result in a decreased 
sensitivity to psychomotor stimulants (Weissman et 
al., 1966; Dominic and Moore, 1969). Inhibition of 
monoamine oxidase (MAO) with pargyline resulted 
in increased sensitivity to the locomotor stimulant 
effects of a series of N-ethyl amphetamines (Tessel 
et al., 1975), consistent with the hypothesis of a drug- 
induced intraneuronal release of catecholamines in 
the brain which produces the locomotor stimulation. 
Narcotic analgesics also produce dose-related in- 
creases in spontaneous locomotor activity; pretreat- 
ment with MAO inhibitors resulted in increased 
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sensi t ivi ty  and  amine  dep le t ion  resul ted in decreased  
sensi t ivi ty to  the l o c o m o t o r  s t imulan t  effects o f  nar -  
cot ics  (Hol l inger ,  1969; Ca r ro l  and  Sharp,  1972; 
Vi l la r rea l  et al. ,  1973), suggest ing tha t  the effect o f  
narco t ics  m a y  also be due  to the release o f  ca techol-  
amines  in the  b ra in  centra l  nervous  system. 
The  present  s tudy  was conduc ted  to de te rmine  if  
the sensi t ivi ty o f  ope ran t  r e spond ing  to the  effects o f  
m o r p h i n e  and  a series o f  s y m p a t h o m i m e t i c  amines  
cou ld  be enhanced  by  dai ly  inject ions o f  the M A O  
inh ib i to r  pargyl ine .  A p r i s o n  and  Fe r s t e r  (1961) previ-  
ously  d e m o n s t r a t e d  an enhanced  sensi t ivi ty o f  p igeons  
to  the  effects o f  5 - h y d r o x y - t r y p t o p h a n  on ope ran t  
behav io r  af ter  M A O  inhib i t ion  by  iproniaz id .  In the 
presen t  s tudy,  pa rgy l ine - induced  increases in sensit iv- 
i ty were de t e rmined  by  c o m p a r i n g  dose-effect  curves 
before  and  dur ing  da i ly  pargyl ine .  P e n t o b a r b i t a l  doses  
were also tested,  since it, l ike amphe t amine ,  p r o d u c e d  
increases in food- re in fo rced  re spond ing  under  a mul-  
t iple  F I - F R  schedule  (Rut ledge  and  Kel leher ,  1965). 
M E T H O D S  
Subjects. Subjects were six male pigeons (three White Carneaux and 
three Silver Kings), weighing between 400 and 600 g when allowed 
free access to food and water. All birds had prior histories of 
operant responding. None had received any drugs for at least 
3 months prior to the start of the study. Birds were deprived of 
food until they reached 80 ~ of their free feeding weights; they were 
maintained at this level by post-session supplemental feeding. 
Apparatus. The three experimental chambers were closely similar 
to those described by Ferster and Skinner (1957). White noise was 
continuously present in each chamber to help mask extraneous 
noise. Chambers were ventilated by exhaust fans. An acrylic 
response key (1.9 cm diameter) could be transilluminated by blue 
or red 7 w light bulbs and was operated by a force equivalent to 
a weight of about 15.0 g. Four seconds access to mixed grain served 
to maintain responding and it was made available through a rectan- 
gular opening in the front wall of the chamber below the response 
key. Electromechanical switching, timing, and counting devices were 
used to control the experiment. 
Procedure. Pigeons were trained to respond by reinforcing successive 
approximations of the key-peck response. Under the terminal 
schedule conditions food was presented following the first response 
after 5 rain in the presence of a red light (fixed-interval 5-rain; FI 5), 
or after the thirthieth response in the presence of a blue key light 
(fixed-ratio 30-response; FR 30). The key lights were extinguished 
and the food hopper was illuminated by a white light during food 
presentation. If a bird did not respond within 60 s after each FI 5 
had elapsed, no food was delivered and the schedule advanced to the 
next FR 30 component. Similarly, if 30 responses were not emitted 
within 60 s in each FR 30 component, no food was delivered and 
the schedule was switched to the next FI 5 component. Each session 
consisted of ten FI 5 and ten FR 30 components which alternated 
throughout the session. Under these schedule conditions, the session 
length was approximately 60 rain. Each bird was run for a minimum 
of 30 days before drug testing. Sessions were conducted daily. 
Stability in all cases was defined as no consistent upward or down- 
ward trend in response rate or quarter-life (QL) across sessions. 
Dose-Effect Curves. Test doses of morphine, pentobarbital, d-am- 
phetamine, tyramine, and pargyline were administered immediately 
before the start of the session. Drugs were dissolved in saline and 
injected into the breast muscle of the bird. Drugs were tested no 
more frequently than every fifth day; saline was injected on 
intervening days. Doses were tested in an increasing dose sequence. 
In the second phase of the experiment, pargytine was admin- 
istered every 12 h, at a dose of 25 mg/kg. One of the two daily injec- 
tions was given immediately before the session. After responding 
had stabilized under the chronic pargyline regimen, morphine, 
d-amphetamine, tyramine, and pentobarbital dose-effect curves 
were re-determined. Drugs were tested every fifth day; on test days 
both pargyline and the test dose were injected before the session. 
Data Analysis. Response rates were calculated in responses/s for 
FI and FR components. QL, a measure of response distribution 
within FI components, was computed on the basis of average re- 
sponse rates innsuccessive 30-s segments of each FI component 
according to the method of Gollub (1964). This statistic represents 
the average amount of time, expressed as a percentage of the total 
FI time, required for the emission of one-fourth of the total responses 
in each FI. 
Drugs. Morphine sulfate, d-amphetamine sulfate, ephedrine sulfate, 
tyramine hydrochloride (grade B, CalBiochem), pargyline hydro- 
chloride (Abbott Labs), and sodium pentobarbital were dissolved 
in 0.9~ saline. Doses refer to the salt. Drug concentrations were 
adjusted so that each bird received 1.0 ml per kg body weight. Drugs 
were injected into the breast muscle of the bird. 
R E S U L T S  
Con t ro l  pe r fo rmance  under  the  mul t ip le  F1 5, F R  30 
schedule  was s imi lar  to  tha t  p rev ious ly  r epo r t ed  for  
this schedule o f  re in forcement  (e.g., Fe r s t e r  and  
Skinner ,  1957; Heife tz  and  M c M i l l a n ,  1971). The  mean  
response  ra te  was 0.51 responses/s  in F I  and  2.05 in 
F R  c o m p o n e n t s  (Fig.  1). F I  r e spond ing  showed the 
charac te r i s t ic  pos i t ive ly  acce lera ted  pa t t e rn  o f  re- 
sponding ,  ind ica ted  by  a Q L  of  0.5J (Fig.  1). F R  30 
r e spond ing  was charac te r i zed  by  a b r ie f  ini t ial  pause,  
fo l lowed by  a high and  relat ively cons t an t  ra te  o f  
responding.  There  was no a p p a r e n t  difference in ei ther  
con t ro l  r e spond ing  or  in the  sensi t ivi ty to  drugs  for  the 
two breeds  o f  p igeons  used. 
Pargy l ine  p r o d u c e d  dose- re la ted  decreases  in all 
measures  o f  the  pa t t e rn  and  ra te  o f  r e spond ing  (Fig.  1). 
F I  r e spond ing  a p p e a r e d  somewha t  more  sensitive 
t han  F R  behav io r  to  pa rgy l ine  in that  a 20 m g / k g  dose  
decreased  F I  rates  to  a b o u t  50 ~o o f  con t ro l  and  did 
no t  change  F R  rates.  A t  50 mg/kg ,  F I  rates were at  or  
close to zero,  while F R  rates were no t  as comple te ly  
suppressed.  One  o f  the  six bi rds  fai led to recover  f rom 
the 50 m g / k g  dose  and  died 3 days  later .  The  o ther  
five bi rds  recovered  to con t ro l  values wi th in  a few 
days.  
Da i ly  inject ions o f  pa rgy l ine  (25 mg/kg ,  every 12 h) 
resul ted  in the deve lopmen t  o f  to le rance  to  the effects 
o f  pa rgy l ine  (Fig.  2). Pargyl ine  ini t ial ly decreased  F I  
and  F R  response  rates and  Q L  value.  S imi lar  to the 
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Fig. l. Effects of pre-session pargytine (e) and saline (O) on FI 
and FR response rates and on fixed-interval quarter-life (QL) values. 
Response rates are expressed in responses per second and QL as a 
percentage of  the 5-min FI. Intramuscular injections were given 
immediately before the start of  the session. Each point is the mean 
(_+ S.E.) of  six observations per dose of  pargyline and 12 observa- 
tions for saline. See Methods for further details of the schedule 
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Fig.2. Changes in sensitivity to the effect of pargyline produced 
by chronic pargyline injections (25 mg/kg, every 12 h). Baseline 
values (O) represent the mean (_+ S.E.) for the last 2 days in each 
of  five birds (n = I0). Each point during chronic pargyIine (O) is 
the mean (_+ S.E.) for one observation in each of five birds (n = 5). 
Pargyline was injected immediately before the session and 12-h 
after the pre-session injection; injections were given 7 days a week 
data described above, FI responding was more sensi- 
tive than FR to the effects of 25 mg/kg pargyline. 
Responding recovered to control rates within the first 
4 days of chronic pargyline and remained at this level 
throughout the remainder of the study. 
Amphetamine produced both increases and de- 
creases in FI response rates and only decreases in FR 
rates (Fig. 3). Analysis of the amphetamine-induced 
changes in responding during individual 30-s segments 
of the FI indicated that the lowest rates were 
increased and higher rates were increased less or 
decreased (Fig.4). Daily pargyline resulted in an 
increased sensitivity to the effects of amphetamine on 
FI responding; the dose-effect curve for FR responding 
was not affected. The pargyline-induced increase in 
sensitivity to amphetamine was also seen in the change 
in the effects of amphetamine on responding in 
individual segments of the FI (Fig.4). A dose that 
initially did not affect FI responding (0.1 mg/kg) 
produced effects equivalent to 0.32 mg/kg after chronic 
pargyline (Figs. 3 and 4). 
In contrast to d-amphetamine, doses of ephedrine 
and tyramine produced only decreases in average 
rates of FI, responding and decreased FR rates (Fig. 3). 
These drugs produced the greatest decreases in the 
highest rates of responding in local FI segments 
(Fig. 4). At the lower response rates the drugs produced 
less of a decrease or slight increases in responding 
(Fig.4). Daily pargyline injection resulted in a shift 
to the left of the tyramine and ephedrine dose-effect 
curves for FI (3- and 10-fold, respectively) and a 
similar increase in the effectiveness of these drugs on 
responding in local segments of the FI (Fig.4). In 
contrast to the other drugs, the tyramine dose-effect 
curve for FR responding was shifted to the left about 
3-fold after chronic pargyline. 
Pentobarbital produced both increases and de- 
creases in FI response rates; FR rates were decreased 
at doses that also decreased FI rates. Relatively low 
rates of responding in local segments of the FI were 
increased more than the relatively high FI rates. In 
contrast to the other drugs tested, chronic pargyline 
did not result in any change in sensitivity to the 
effects of pentobarbital on responding. 
Morphine produced dose-related decreases in FI 
and FR responding. After chronic pargyline the dose- 
effect curve for FI was shifted slightly to the left. The 
increase in morphine sensitivity after pargyline was 
reflected in changes in the effectiveness of morphine 
on responding in local segments of the FI. 
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Fig. 3. Pargyline-induced changes in sensitivity to the effects of d-amphetamine, ephedrine, tyramine, pentobarbital and morphine on 
FI (zx, ~,) and FR (O, O) responding. Open symbols represent the effects of the different drugs (9 and saline (S) on FI and FR responding 
prior to chronic pargyline. Solid symbols represent the effects of saline and the drugs on responding after more than 14 days of daily 
pargyline (25 mg/kg, every 12 h). Each point is the mean (_+ S.E.) of 5 observations per dose; drugs were given immediately before the start 
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Fig.4. Changes in the effects of d-amphetamine, ephedrine, tyramine, pentobarbital, and tyramine on responding in 30 s segments of the 
FI (small symbols) and on FR rates (larger symbols). Open symbols represents the effects of the drugs on responding prior to chronic 
pargyline and solid symbols represent drug induced changes in responding are plottedd as the ratio of the rate of responding after drug 
divided by the control rate (D/C) time J00 vs. the control average response rate for that 30 s segment of the FI. Least squares regression line, 
for the FI date only, are plotted for each drug both before chronic pargyline (- -Q and during chronic pargyline ( ). For reference, 
a no-effect line would be paralleled to the x axis at the 100-D/C. Drugs were given immediately before the session 
D I S C U S S I O N  
Both  pentobarbi ta l  and d-amphetamine  produced  
increases and decreases in F I  response rates. Mor -  
phine, ephedrine, and tyramine produced  only de- 
creases in the average rate o f  F I  responding.  All the 
drugs p roduced  only decreases in F R  response rates. 
The sensitivity o f  F I  responding was increased after 
daily pargyline (25 mg/kg  every 12h) for all the drugs 
except pentobarbital .  
As with m a n y  other  centrally-active drugs, a range 
o f  acute pargyline doses p roduced  decreases in F!  and 
F R  response rates and QL. F I  responding appeared 
to be more  sensitive to pargyline at the 20, 25, and 
50 mg/kg  doses. Chronic  adminis t rat ion o f  pargyline 
at 25 mg/kg  (i.m., every 12 h) resulted in an initial 
decrease in bo th  F I  and F R  response rates. Tolerance 
developed to pargyline, evidenced by a progressive 
recovery o f  responding across days. In  addit ion to 
pargyline, tolerance has been reported to develop to 
the behavioral  effects o f  me thadone  and morphine  
(Heifetz and McMillan,  1971), delta-9-tetrahydro- 
cannabinol  (McMil lan et al., 1971), d-amphetamine  
(Schuster et al., 1966; F i schman and Schuster, 1975), 
sedative hypnotics,  and  ethyl alcohol (Kalant  et al., 
1971). The data  for  pargyline demonst ra te  that  the 
p h e n o m e n o n  of  tolerance to the behavioral  effects 
o f  a drug can be extended to include such c o m p o u n d s  
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as the monoamine oxidase inhibitors, of which pargy- 
line is one example. 
Morphine sensitivity was increased by about 3-fold 
for FI responding after daily pargyline. Increases in 
sensitivity to morphine as a result of pargyline or 
iproniazid pretreatment have been reported for stimu- 
lation of spontaneous motor activity in rodents (Hol- 
linger, 1967; Carroll and Sharp, 1972; Villarreal et al., 
1973) and for morphine-induced analgesia (Yeh and 
Mitchell, 1971). Morphine results in increases in 
catecholamine turnover (Smith et al., 1972). Pretreat- 
ments with drugs that decrease catecholamine content 
by interfering with synthesis or storage reduce the 
stimulant effects of morphine on locomotor activity 
(Hollinger, 1969; Villareal et al., 1973). These and 
other data have led to the hypothesis that the effects 
of morphine are mediated in part by its effects on 
catecholamines in the central nervous system. The 
increased sensitivity to morphine effects on FI re- 
sponding after the chronic administration of pargyline 
are consistent with the hypothesis that the effects of 
morphine on operant responding are mediated by its 
effects on brain monoamines. Since both catechol- 
amines and indoleamines are metabolized via mono- 
amine oxidase, it is not possible to determine which 
of these amines are responsible for the effects of mor- 
phine on operant behavior. 
In addition to morphine, sensitivity to d-amphet- 
amine was increased after chronic pargyline for both 
the drug-induced increases and decreases in respond- 
ing. Amphetamine produced increases in FI respond- 
ing at 0.32 and 1.0 mg/kg. Lower doses had no effect 
on responding and higher doses decreased FI rates. 
Similar d-amphetamine-induced increases and de- 
creases in FI responding have been reported for 
pigeons (McMillan, 1968 a) and monkeys (McMillan, 
1968 b; McKearney, 1974; Herling et al., 1975). After 
chronic pargyline, the amphetamine dose-effect curves 
for FI and FR responding were shifted to the left. 
Similar increases in amphetamine sensitivity after 
pretreatment with monoamine oxidase inhibitors such 
as pargyline and iproniazid have been reported for 
stimulation of spontaneous motor activity in mice 
and stimulation of guinea pig atrial rate (Smith, 1965, 
1966). The other sympathomimetic amines, only de- 
creased average FI rates. McMillan (1968a) reported 
that ephedrine increased FI rates at doses between 
1.0 and 3.0 mg/kg. In the present study, ephedrine only 
decreased FI responding at doses between 0.1 and 
10.0 mg/kg. However, some increases in the relatively 
low rates of responding in local segments of the FI 
were observed for both tyramine and ephedrine and 
to this extent the data are similar to that of McMillan 
(1968 a). 
Chronic pargyline enhanced the sensitivity to the 
effects of the tyramine on both local FI rates and 
overall FI and FR response rates. Tyramine is a good 
substrate for MAO and some of the shift to the left 
for tyramine, which was 3 timesgreater than any of the 
other drugs, may have been due to an inhibition of 
tyramine metabolism. In addition to the possible 
increase in functional dose of tyramine due to inhibi- 
tion of metabolism, tyramine is an indirectly-acting 
amine and some of the enhanced sensitivity may be due 
to an inhibition of biogenic amine metabolism. In 
the peripheral nervous system, tyramine acts by 
releasing endogenous norepinephrine within adren- 
ergic nerves (Smith, 1966), and the effects of tyramine 
are enhanced after pargyline (Antanaccio and Smith, 
1969). On the other hand, ephedrine has an alpha- 
methyl group and, consequently, is less likely to serve 
as a substrate for MAO. Thus, the shift to the left of 
the ephedrine dose-effect curve is more likely to be the 
result of the inhibition of biogenic amine metabolism. 
The data for pentobarbital demonstrate that 
chronic pargyline does not necessarily result in an 
increased sensitivity to the behavioral effects of all 
drugs. Pentobarbital increased FI responding at 
3.2 mg/kg and decreased rates at 10 mg/kg. Chronic 
pargyline did not result in any changes in the pento- 
barbital dose-effect curves. 
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